Cowen and Company’s Aimei Health Technology Co Unit AFJKU Stock Holding History

Cowen and Company’s Portfolio AFJKU Stock Details AFJKU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-476,428	Closed	-$4.86M	–	812
2023 Q4	$4.86M	Buy	+476,428	New	+$4.84M	0.32%	52

Other funds holding AFJKU

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cowen and Company's AFJKU Position: Q1 2024 in Review

Cowen and Company sold out of Aimei Health Technology Co Unit (AFJKU) in Q1 2024, closing a stake of 476,428 shares — an estimated $4.86M sold.

Cowen and Company first reported a position in AFJKU in Q4 2023 and held it in 1 quarter. The position peaked at $4.86M in Q4 2023. 6 funds tracked by Wall St. Rank hold AFJKU as of Q1 2024.

Cowen and Company reported no remaining Aimei Health Technology Co Unit position as of Q1 2024 after selling out during the quarter.
Cowen and Company sold 476,428 Aimei Health Technology Co Unit shares in Q1 2024, an estimated $4.86M.
Cowen and Company first reported a position in Aimei Health Technology Co Unit in Q4 2023 and held it in 1 quarter.
Cowen and Company's Aimei Health Technology Co Unit position peaked at $4.86M in Q4 2023.
6 funds tracked by Wall St. Rank held Aimei Health Technology Co Unit as of Q1 2024.

Based on Cowen and Company's 13F filing for Q1 2024, filed 3 May 2024.